You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
5 June 2026 - Biopharmaceutical company Gilead Sciences Inc (Nasdaq: GILD) and biotechnology company Lakefront Biotherapeutics NV (Euronext & Nasdaq: LKFT), formerly known as Galapagos, confirmed late Thursday the successful completion of the pre...
5 June 2026 - India-based global pharmaceutical company Lupin Limited (BSE: 500257) (NSE: LUPIN) announced on Thursday that the US Food and Drug Administration (FDA) has approved its ranibizumab, Ranluspec (ranibizumab-hkdz), as an interchangeable bi...
5 June 2026 - Breckenridge Pharmaceutical Inc, the US subsidiary of Spain-based Towa International that markets, distributes, and sells generic medicines in the United States, announced on Thursday the launch of Tofacitinib Tablets, the generic equiv...
5 June 2026 - Biotechnology company HotSpot Therapeutics Inc announced on Thursday the presentation of preclinical data from its interferon regulatory factor 5 (IRF5) programme in a poster presentation at the European Congress of Rheumatology (EULAR)...
5 June 2026 - Chinese clinical-stage company Lupeng Pharmaceutical Ltd announced on Thursday that China's National Medical Products Administration (NMPA) has granted accelerated approval to rocbrutinib (development code: LP-168) for the treatmen...
4 June 2026 - Specialty biopharmaceutical company RedHill Biopharma Ltd (Nasdaq:RDHL) announced on Wednesday that it is actively discussing potential collaborations for advancement of its investigational oral drug, opaganib, to combat Ebola virus dis...
3 June 2026 - Healthcare technology company Medtronic (NYSE: MDT) reported on Wednesday that it has submitted multiple 510(k) applications to the U.S. Food and Drug Administration aimed at expanding the clinical use of its Hugo robotic-assisted surge...